Dr. Nagel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Summary
- I am an Associate Professor in Neurology at the University of Colorado School of Medicine in Aurora, CO, fellowship trained in Neurovirology. In my clinical practice, I see general neurology patients, as well as those with complications from neurotropic viruses, including varicella zoster virus (VZV) and herpes simplex virus-1/2 (HSV-1, HSV-2). My NIH-funded laboratory focuses on pathological cerebrovascular remodeling due to VZV infection of arteries, manifesting clinically as aneurysms and hemorrhagic/ischemic stroke; characterization of other forms of VZV vasculopathy, including Giant Cell Arteritis and Takayasu's Arteritis, and; the role of HSV-1/2 reactivation in atypical facial pain, burning mouth syndrome, and chronic headaches.
Use the following link to get PDF versions of my articles:
http://www.ucdenver.edu/academics/colleges/medicalschool/departments/neurology/Faculty/Documents/MD_CV%202015/CV_Nagel%20MASTER_04.09.15.pdf
Education & Training
- University of ColoradoResidency, Neurology, 2003 - 2006
- University of ColoradoInternship, Internal Medicine, 2002 - 2003
- University of Illinois College of MedicineClass of 2002
Certifications & Licensure
- CO State Medical License 2006 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 6 citationsExpanding the clinical and neuroimaging features of post-varicella arteriopathy of childhoodMarta Bertamino, Sara Signa, Marco Veneruso, Giulia Prato, Roberta Caorsi
Journal of Neurology. 2021-05-27 - 67 citationsVirus vasculopathy and stroke: an under-recognized cause and treatment target.Maria A. Nagel, Ravi Mahalingam, Randall J. Cohrs, Donald H. Gilden
Infectious Disorders Drug Targets. 2010-04-01 - 68 citationsVaricella-zoster virus vasculopathy Immune characteristics of virus-infected arteriesMaria A. Nagel, Igor Traktinskiy, Kurt R. Stenmark, Maria G. Frid, Alexander Choe
Neurology. 2013-01-01
Journal Articles
- Varicella Zoster Virus Productively Infects Human Peripheral Blood Mononuclear Cells to Modulate Expression of Immunoinhibitory Proteins and Blocking PD-L1 Enhances Vi...David M Koelle, Maria A Nagel, PLoS One
- Reactivation of Simian Varicella Virus (SVV) in Rhesus Macaques After CD4 T Cell DepletionMaria Nagel, MD, mBio
Other
- Varicella Zoster Virus VasculopathyMaria Nagel, MD, The Journal of Infectious Diseases
https://www.doximity.com/articles/5621df86-6458-49c6-83a1-5fac314f1827
UpToDate, Wolters Kluwer Health - 2012-12-12
Press Mentions
- Can Vaccinations Help Prevent Dementia? Research Shows That the Disorder Is Linked to VirusesFebruary 12th, 2023
- Can Vaccines Help Prevent Dementia? Research Indicates That the Disorder Is Linked to a VirusFebruary 12th, 2023
- Could VACCINES Help Prevent Dementia? Research Indicates the Disorder Is Linked to a VirusesFebruary 12th, 2023
- Join now to see all
Grant Support
- Purinergic Signaling in Varicella Zoster Virus VasculopathyNational Institute of Neurological Disease and Stroke2015–2019
- The Molecular Pathogenesis of Varicella Zoster Virus InfectionNational Institute of Aging2014–2019
- Mechanisms By Which VZV IE Proteins Interact With Cell Antiviral Proteins To PrevNational Institute Of Neurological Disorders And Stroke2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: